Replies to post #167117 on Biotech Values

[DewDiligence]

RGDO’s REGULATE-PCI study is one of the highest-risk phase-3 trials I’ve ever seen conducted by a small biotech company without a partner. The cost of running the trial is $150M, according to today’s webcast.

Clinicaltrials.gov listing: http://www.clinicaltrials.gov/ct2/show/NCT01848106 .